4 Result(s)
within
David J. Jackson
Endocrinology
-
Article
Open AccessGreenhouse Gas Emissions from Respiratory Treatments: Results from the SABA CARBON International Study
Healthcare systems are looking to reduce their carbon impact. Short-acting β2-agonist (SABA) overuse (≥ 3 canisters/year) is common in asthma and linked to poor outcomes; however, its environmental impact remains...
-
Article
Open AccessA Renewed Charter: Key Principles to Improve Patient Care in Severe Asthma
Asthma is a heterogenous respiratory disease, usually associated with chronic airway inflammation and hyper-responsiveness, which affects an estimated 339 million people worldwide. Severe asthma affects approx...
-
Article
Open AccessImproving Care in Eosinophil-Associated Diseases: A Charter
Eosinophil-associated diseases (EADs) are a range of heterogeneous conditions in which eosinophils are believed to play a critical pathological role. EADs include common illnesses such as eosinophilic asthma a...
-
Article
Open AccessAbility of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients with Severe Eosinophilic Asthma
For patients with eosinophilic asthma with allergic characteristics, understanding the key drivers of exacerbations is important to identify optimal treatment strategies. Benralizumab is an interleukin-5 recep...
